Hepatitis B
2 articles

Cosmos & Space
Bepirovirsen data shows functional cure in 19% of hepatitis B patients
An experimental hepatitis B treatment achieved a 'functional cure' in nearly 1 in 5 patients during its pivotal Phase 3 studies, a significant stride against a chronic viral infection that afflicts mi
David Grossman·May 28, 2026

Cosmos & Space
New drug Bepirovirsen functionally cures hepatitis B in some patients
In two late-stage clinical trials, GSK's experimental drug Bepirovirsen achieved a functional cure for 19% of patients with chronic hepatitis B, a disease that has long resisted effective treatment.
David Grossman·May 28, 2026